Author(s)

Tovar-Hernández Karla¹, Ruíz-Cruz Matilde², Marco Antonio Meraz-Ríos^1*

¹Department of Molecular Biomedicine, Cinvestav Zacatenco, Mexico City, Mexico.
²Research Department, Asociación Para Evitar la Ceguera, Mexico City, Mexico.

The Retinoblastoma 1 (RB1) gene, located on chromosome 13q14 and encodes the tumor-suppressor retinoblastoma protein, is the cause of Retinoblastoma. The mutational inactivation of both gene alleles brings on this cancer. Retinoblastoma (RB) high-risk histopathological characteristics indicate metastasis or local recurrence with rapid progresses following RB1 inactivation. There is growing interest in regulatory activities unconnected to the coding region of the genome, or exome, in addition to epigenetic control mechanisms. The altered epigenome is significant, though by no means the only, problem in the etiology of Retinoblastoma. After all, cancer development is a multistep process in which numerous dissimilar genetic, epigenetic, and posttranscriptional modifications result in a shared phenotype. This study emphasizes the most recent developments in posttranscriptional change and epigenetics related to retinoblastoma tumor biology. Here, we highlight the novel biomarkers the retinoblastoma tumor has expressed to improve patient survival.

Retinoblastoma, Epigenetic, ncRNAs, miRNAs, lncRNAs, circRNAs, ceRNAs

Karla, T. , Matilde, R. and Meraz-Ríos, M. (2023) Epigenetic and Posttranscriptional Regulation in Retinoblastoma. Advances in Bioscience and Biotechnology, 14, 190-209. doi: 10.4236/abb.2023.144013.